---
title: "Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292116310.md"
description: "Corbus Pharmaceuticals (CRBP) shares rose 1.81% to $9.55 on Wednesday, marking two consecutive days of gains. Despite this daily increase, the stock underperformed relative to competitors like Vanda Pharmaceuticals and Fortress Biotech. Trading volume was below the 50-day average, and the share price remains significantly below its 52-week high."
datetime: "2026-07-08T21:17:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292116310.md)
  - [en](https://longbridge.com/en/news/292116310.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292116310.md)
generator: "portal-rs"
---

# Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. (CRBP) rallied 1.81% to $9.55 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.20% to 25,870.65 and the Dow Jones Industrial Average falling 1.09% to 52,348.39.

This was the stock's second consecutive day of gains.

Corbus Pharmaceuticals Holdings Inc. closed 53.55% short of its 52-week high of $20.56, which the company reached on October 20th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. (VNDA) rose 2.97% to $6.58, Fortress Biotech Inc. (FBIO) rose 0.33% to $3.00, and Viking Therapeutics Inc. (VKTX) fell 5.15% to $39.96.

Trading volume (490,863) remained 59,510 below its 50-day average volume of 550,373.

Data source: Dow Jones Market Data, FactSet. Data compiled July 8, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-08-26 1717ET

### Related Stocks

- [CRBP.US](https://longbridge.com/en/quote/CRBP.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [VNDA.US](https://longbridge.com/en/quote/VNDA.US.md)
- [FBIO.US](https://longbridge.com/en/quote/FBIO.US.md)
- [VKTX.US](https://longbridge.com/en/quote/VKTX.US.md)
- [FBIOP.US](https://longbridge.com/en/quote/FBIOP.US.md)

## Related News & Research

- [Corbus Pharma CFO Sean Moran sells 12,000 shares for $120,971](https://longbridge.com/en/news/295447150.md)
- [Corbus Pharma CMO Nicacio Leonardo Viana files initial beneficial ownership statement](https://longbridge.com/en/news/294867785.md)
- [Samsung Biologics publishes prospectus for PolyPeptide public tender offer](https://longbridge.com/en/news/297464401.md)
- [BUZZ-Mid-cap drugmakers face limited impact from Trump drug pricing deals, analysts say](https://longbridge.com/en/news/297637201.md)
- [Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains](https://longbridge.com/en/news/297832387.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**